A four‐mRNA signature (CHRNA2, NPR3, VGLL3 and PAH) was found in primary tumour tissue samples from pN1 PCa patients, and then it was validated using the TCGA‐PRAD and GSE220095 datasets. This evidence concerns the gene CHRNA2 and neoplasm.